Wolfgang G. Sauerwein

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Quantification of 10B and 11B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT).

Quantification of 10B and 11B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT).

Journal: Medicinal research reviews

Published: November 03, 2025

Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: ESMO open

Published: September 24, 2025

Metastatic disease in conjunctival malignant melanoma: a retrospective analysis of 167 cases.

Metastatic disease in conjunctival malignant melanoma: a retrospective analysis of 167 cases.

Journal: BMJ open ophthalmology

Published: May 13, 2025

In-vitroand microdosimetric study of proton boron capture therapy and neutron capture enhanced proton therapy.

In-vitroand microdosimetric study of proton boron capture therapy and neutron capture enhanced proton therapy.

Journal: Physics in medicine and biology

Published: November 25, 2024

Novel Drug Delivery Particles Can Provide Dual Effects on Cancer "Theranostics" in Boron Neutron Capture Therapy.

Novel Drug Delivery Particles Can Provide Dual Effects on Cancer "Theranostics" in Boron Neutron Capture Therapy.

Journal: Cells

Published: November 24, 2024

Anatomical outcome after brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.

Anatomical outcome after brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.

Journal: Radiation oncology (London, England)

Published: October 03, 2024

Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.

Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.

Journal: Radiation oncology (London, England)

Published: September 26, 2024

Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma.

Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma.

Journal: European journal of ophthalmology

Published: May 29, 2024

Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma.

Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 08, 2024

Charged particle radiotherapy for thyroid cancer. A systematic review.

Charged particle radiotherapy for thyroid cancer. A systematic review.

Journal: Critical reviews in oncology/hematology

Published: April 11, 2024

Early Stage In Vitro Bioprofiling of Potential Low-Molecular-Weight Organoboron Compounds for Boron Neutron Capture Therapy (BNCT)-Proposal for a Guide.

Early Stage In Vitro Bioprofiling of Potential Low-Molecular-Weight Organoboron Compounds for Boron Neutron Capture Therapy (BNCT)-Proposal for a Guide.

Journal: Cells

Published: March 05, 2024

Treatment-Related Complications and Functional Results after Ruthenium-106 Brachytherapy in Small to Medium Size Uveal Melanomas (Part 2).

Treatment-Related Complications and Functional Results after Ruthenium-106 Brachytherapy in Small to Medium Size Uveal Melanomas (Part 2).

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: February 23, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026